JB
Insider
Jeffrey Bluestone
DirectorJeffrey Bluestone (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Gilead Sciences, Inc. (GILD). The largest single filing was $672K of GILD (4,639 sh across 3 lots, as filed), executed Aug 20.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.9M
shares × price, as filed
Last traded
Aug 20
Filed Aug 21
Median ADV $1.0B across their filed names
Open performance→Volume by month
Buys $0
Sells $3.1M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
3 filings
Sector per market data · by filing · past 12 months
Most traded names
GILDRecent filings
GILDSALE
Gilead Sciences, Inc.
View filing →
$672K4,639 sh across 3 lots
Exec Aug 20
Filed Aug 21 · 7:22 PM ET GILDSALE Gilead Sciences, Inc. View filing → $618K
5,000 sh × $123.50
Exec Jan 20
Filed Jan 21 · 5:30 PM ET GILDSALE Gilead Sciences, Inc. View filing → $625K
5,000 sh × $125.08
Exec Nov 28 2025
Filed Dec 1 2025 · 5:30 PM ET GILDSALE Gilead Sciences, Inc. View filing → $549K
5,000 sh × $109.74
Exec Jul 14 2025
Filed Jul 15 2025 · 5:30 PM ET GILDSALE Gilead Sciences, Inc. View filing → $620K
6,788 sh × $91.39
Exec Nov 26 2024
Filed Nov 27 2024 · 5:30 PM ET